Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta3 integrin expression in melanoma predicts subsequent metastasis

T J Hieken1, M Farolan, S G Ronan

  • 1Department of Surgical Oncology, University of Illinois at Chicago 60612, USA.

The Journal of Surgical Research
|June 1, 1996
PubMed
Summary

Beta3 integrin expression in primary cutaneous melanoma is linked to thicker tumors and poorer patient outcomes. This finding suggests beta3 integrin as a potential prognostic marker for melanoma metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database.

The British journal of surgery·2020
Same author

Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.

HIV medicine·2019
Same author

Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2014
Same author

p28, a first in class peptide inhibitor of cop1 binding to p53.

British journal of cancer·2013
Same author

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.

British journal of cancer·2013
Same author

Transformation of human breast epithelial cells by 7, 12, dimethylbenz(a)anthracene, but not by N-methyl-N-nitrosourea, is accompanied by up-regulation of basic fibroblast growth factor.

Oncology reports·2011

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Integrins, particularly alphaVbeta3, are implicated in melanoma metastasis and angiogenesis.
  • The clinical prognostic value of beta3 integrin expression in human malignant melanoma remains unclear.

Purpose of the Study:

  • To investigate the prognostic significance of beta3 integrin expression in primary cutaneous melanoma.
  • To correlate beta3 integrin expression with tumor characteristics and patient survival outcomes.

Main Methods:

  • Analysis of 160 primary cutaneous melanoma patient samples with a mean follow-up of 98 months.
  • Quantification of beta3 integrin expression using CD-61 antibody and image analysis.
  • Statistical correlation of beta3 integrin status with tumor thickness, relapse rates, and overall survival.

Related Experiment Videos

Main Results:

  • Beta3 integrin expression was detected in 69% of primary melanomas.
  • Beta3 integrin-positive tumors were significantly thicker than negative tumors (2.98 mm vs 1.64 mm).
  • Patients with beta3 integrin-positive melanomas had higher rates of relapse (53% vs 11%) and mortality (42% vs 8%), with shorter overall survival (69 months vs 102 months).

Conclusions:

  • Beta3 integrin expression in primary cutaneous melanoma serves as a significant predictor of subsequent metastatic progression.
  • These findings highlight beta3 integrin as a potential prognostic biomarker for melanoma.
  • Further research into beta3 integrins may offer new therapeutic strategies for melanoma treatment.